Jayant Aphale's Net Worth

$3.29 Million

Estimate Recalculated Sep 16, 2024 07:07PM EST

Who is Jayant Aphale?

Jayant Aphale has an estimated net worth of $3.29 Million. This is based on reported shares across multiple companies, which include Gritstone Oncology, Inc., and Sarepta Therapeutics, Inc..

SEC CIK

Jayant Aphale's CIK is 0001574696

Past Insider Trading and Trends

2016 was Jayant Aphale's most active year for acquiring shares with 7 total transactions. Jayant Aphale's most active month to acquire stocks was the month of January. 2016 was Jayant Aphale's most active year for disposing of shares, totalling 5 transactions. Jayant Aphale's most active month to dispose stocks was the month of August. 2016 saw Jayant Aphale paying a total of $161,700.00 for 67,352 shares, this is the most they've acquired in one year. In 2016 Jayant Aphale cashed out on 70,765 shares for a total of $1,931,643.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gritstone Oncology, Inc. (GRTS) Snapshot price: $0.47

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92

VP, Technical Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$27.31
-$1,588,300.00
11.49K
Scheduled
Sep 19
Form 4
-6.24%
-765.00
$26.07
-$19,943.55
11.49K
Aug 31
Form 4
+23.75%
2.35K
—
—
12.26K
Feb 29
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Feb 28
Form 4
-65.21%
-15.93K
$12.56
-$200,134.41
8.5K
Nov 12
Form 4
—
0
—
—
0
Jun 4
Form 3
—
0
—
—
0
No matching records found